BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 14556234)

  • 1. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse.
    Zocchi A; Girlanda E; Varnier G; Sartori I; Zanetti L; Wildish GA; Lennon M; Mugnaini M; Heidbreder CA
    Synapse; 2003 Dec; 50(4):293-302. PubMed ID: 14556234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
    Cadoni C; Di Chiara G
    J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C; Feldon J
    Synapse; 1998 Aug; 29(4):310-22. PubMed ID: 9661249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A differential activation of dopamine output in the shell and core of the nucleus accumbens is associated with the motor responses to addictive drugs: a brain dialysis study in Roman high- and low-avoidance rats.
    Lecca D; Piras G; Driscoll P; Giorgi O; Corda MG
    Neuropharmacology; 2004 Apr; 46(5):688-99. PubMed ID: 14996546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core.
    McKittrick CR; Abercrombie ED
    J Neurochem; 2007 Mar; 100(5):1247-56. PubMed ID: 17241132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocaine-induced dopamine overflow within the nucleus accumbens measured by in vivo microdialysis: a meta-analysis.
    Frank ST; Krumm B; Spanagel R
    Synapse; 2008 Apr; 62(4):243-52. PubMed ID: 18236471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine differentially affects dopamine transmission in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
    Cadoni C; Muto T; Di Chiara G
    Neuropharmacology; 2009; 57(5-6):496-501. PubMed ID: 19647004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell.
    Tizabi Y; Bai L; Copeland RL; Taylor RE
    Alcohol Alcohol; 2007; 42(5):413-6. PubMed ID: 17686828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent morphine treatment induces a long-lasting increase in cholinergic modulation of GABAergic synapses in nucleus accumbens of adult rats.
    De Rover M; Lodder JC; Schoffelmeer AN; Brussaard AB
    Synapse; 2005 Jan; 55(1):17-25. PubMed ID: 15499607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C; Valentini V; Di Chiara G
    J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens.
    Pontieri FE; Tanda G; Di Chiara G
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12304-8. PubMed ID: 8618890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats.
    Hemby SE; Co C; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):274-80. PubMed ID: 9862781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs.
    Jonsson S; Adermark L; Ericson M; Söderpalm B
    Neuropharmacology; 2014 Jul; 82():69-75. PubMed ID: 24686030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release.
    Peleg-Raibstein D; Feldon J
    Neuropharmacology; 2006 Oct; 51(5):947-57. PubMed ID: 16876207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens.
    Quarta D; Di Francesco C; Melotto S; Mangiarini L; Heidbreder C; Hedou G
    Neurochem Int; 2009 Feb; 54(2):89-94. PubMed ID: 19118592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-induced dopamine elevation in the rat--modulatory effects by subchronic treatment with nicotinic drugs.
    Löf E; Chau PP; Stomberg R; Söderpalm B
    Eur J Pharmacol; 2007 Jan; 555(2-3):139-47. PubMed ID: 17141214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered extracellular levels of DOPAC and HVA in the rat nucleus accumbens shell in response to sub-chronic nandrolone administration and a subsequent amphetamine challenge.
    Birgner C; Kindlundh-Högberg AM; Nyberg F; Bergström L
    Neurosci Lett; 2007 Jan; 412(2):168-72. PubMed ID: 17123707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and drug addiction: the nucleus accumbens shell connection.
    Di Chiara G; Bassareo V; Fenu S; De Luca MA; Spina L; Cadoni C; Acquas E; Carboni E; Valentini V; Lecca D
    Neuropharmacology; 2004; 47 Suppl 1():227-41. PubMed ID: 15464140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.